Format: PDF
The Global In Vitro Diagnostics (IVD) Market is calculated to reach USD 92.11 billion by 2025, growing at a CAGR of 5.76% during the forecast period 2020-2025. The rising demand for early and accurate disease diagnosis, increasing adoption of fully-automated instruments and automation in laboratories, increasing adoption of point-of-care testing, and growing awareness of personalized medicine are the key factors driving the growth of the market.
1 U.S. In Vitro Diagnostics (IVD) Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 U.S. In Vitro Diagnostics (IVD) Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 U.S. In Vitro Diagnostics (IVD) Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 U.S. In Vitro Diagnostics (IVD) Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 U.S. In Vitro Diagnostics (IVD) Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 U.S. In Vitro Diagnostics (IVD) Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Supplier and distributor analysis (Market share and product dealing strategies)
8 U.S. In Vitro Diagnostics (IVD) Market – By Product (Market Size – & million/billion)
8.1 Reagents & Kits
8.2 Instruments
8.3 Services
9 U.S. In Vitro Diagnostics (IVD) Market – By Technology
9.1 Immunoassay
9.2 Hematology
9.3 Clinical Chemistry
9.4 Molecular Diagnostics
9.5 Coagulation
9.6 Microbiology
9.7 Others
10 U.S. In Vitro Diagnostics (IVD) Market – By Application
10.1 Infectious Diseases
10.2 Diabetes
10.3 Autoimmune Diseases
10.4 Nephrology
10.5 Oncology
10.6 Cardiology
10.7 Drug Testing/Pharmacogenomics
10.8 HIV/Aids
10.9 Other
11 U.S. In Vitro Diagnostics (IVD) Market – By End-User
11.1 Hospitals
11.2 Laboratories
11.3 Point-Of-Care Testing
11.4 Patient Self-Testing
11.5 Academic Institutes
12 U.S. In Vitro Diagnostics (IVD) Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 U.S. In Vitro Diagnostics (IVD) Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Thermo Fisher Scientific
13.3 Siemens AG
13.4 Sysmex Corporation
13.5 Danaher Corporation
13.6 Johnson & Johnson
13.7 Agilent Technologies
13.8 Roche Diagnostics
13.9 Becton, Dickinson and Company
13.10 Bio-Rad Laboratories, Inc.
13.11 Qiagen
13.12 Company 11 & more
14 U.S. In Vitro Diagnostics (IVD) Market – Appendix
14.1 Sources
14.2 Abbreviations
Take a look at this complimentary sample which comprises of a variety of market data points such as trend analyses, market estimates, and forecasts. You can explore and evaluate it on your own.
Send me Free SampleOr View Our License Options:
$3,850.00 – $5,850.00
Industry Coverage: Global Market Studies has a broad range of industry coverage, spanning various sectors such as healthcare, technology, retail, automotive, and many others. This means that clients can rely on us to provide valuable insights into their respective industries, helping them make informed business decisions.
Our team of experts has years of experience in the market research industry, and they have honed their skills in data analysis, market forecasting, and trend analysis. They are also adept at using advanced research tools and techniques to gather and analyze data, providing clients with accurate and reliable insights.
We understand that each client has unique research needs, and we tailor our research solutions to meet their specific requirements. We work closely with our clients to understand their objectives and provide customized research solutions that address their business challenges.
We are committed to innovation and are constantly exploring new research methods and techniques to provide our clients with cutting-edge insights. This enables us to stay ahead of the curve and deliver the best possible research outcomes.
At Global Market Studies, our clients are at the center of everything we do. We pride ourselves on providing excellent customer service and support, and we are always available to address our clients’ concerns and questions.
Accurate market data is crucial to a successful business strategy. With an 85% + accuracy in all reports, makes us one of the best and most accurate firms in the world.
Need Customized Report ?Call NowThe Global In Vitro Diagnostics (IVD) Market is calculated to reach USD 92.11 billion by 2025, growing at a CAGR of 5.76% during the forecast period 2020-2025. The rising demand for early and accurate disease diagnosis, increasing adoption of fully-automated instruments and automation in laboratories, increasing adoption of point-of-care testing, and growing awareness of personalized medicine are the key factors driving the growth of the market.
1 U.S. In Vitro Diagnostics (IVD) Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 U.S. In Vitro Diagnostics (IVD) Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 U.S. In Vitro Diagnostics (IVD) Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 U.S. In Vitro Diagnostics (IVD) Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 U.S. In Vitro Diagnostics (IVD) Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 U.S. In Vitro Diagnostics (IVD) Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Supplier and distributor analysis (Market share and product dealing strategies)
8 U.S. In Vitro Diagnostics (IVD) Market – By Product (Market Size – & million/billion)
8.1 Reagents & Kits
8.2 Instruments
8.3 Services
9 U.S. In Vitro Diagnostics (IVD) Market – By Technology
9.1 Immunoassay
9.2 Hematology
9.3 Clinical Chemistry
9.4 Molecular Diagnostics
9.5 Coagulation
9.6 Microbiology
9.7 Others
10 U.S. In Vitro Diagnostics (IVD) Market – By Application
10.1 Infectious Diseases
10.2 Diabetes
10.3 Autoimmune Diseases
10.4 Nephrology
10.5 Oncology
10.6 Cardiology
10.7 Drug Testing/Pharmacogenomics
10.8 HIV/Aids
10.9 Other
11 U.S. In Vitro Diagnostics (IVD) Market – By End-User
11.1 Hospitals
11.2 Laboratories
11.3 Point-Of-Care Testing
11.4 Patient Self-Testing
11.5 Academic Institutes
12 U.S. In Vitro Diagnostics (IVD) Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 U.S. In Vitro Diagnostics (IVD) Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Thermo Fisher Scientific
13.3 Siemens AG
13.4 Sysmex Corporation
13.5 Danaher Corporation
13.6 Johnson & Johnson
13.7 Agilent Technologies
13.8 Roche Diagnostics
13.9 Becton, Dickinson and Company
13.10 Bio-Rad Laboratories, Inc.
13.11 Qiagen
13.12 Company 11 & more
14 U.S. In Vitro Diagnostics (IVD) Market – Appendix
14.1 Sources
14.2 Abbreviations
Unleashing revenue potential through strategic market research involves identifying untapped market opportunities, understanding consumer needs and preferences, and developing targeted strategies to capitalize on them. By leveraging data-driven insights, businesses can optimize product offerings, pricing strategies, and marketing efforts to drive revenue growth and stay ahead of competitors.
